Amines that inhibit a mammalian anandamide transporter, and...

C - Chemistry – Metallurgy – 07 – C

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07C 215/00 (2006.01) C07C 211/00 (2006.01) C07C 217/58 (2006.01) C07D 307/14 (2006.01) C07B 61/00 (2006.01)

Patent

CA 2486055

One aspect of the present invention relates to amines. A second aspect of the present invention relates to the use of the amines as inhibitors of a mammalian anandamide transporter. The compounds of the present invention will also find use in the treatment of numerous ailments, conditions and diseases which afflict mammals, including but not limited to asthma, neuropathic pain, persistent pain, inflammatory pain, hyperactivity, hypertension, brain ischemia, Parkinson~s disease, spasticity. Tourette~s syndrome, schizophrenia, hemorrhagic shock, septic shock, cardiac shock, migrane, Horton~s headache, multiple sclerosis, anorexia, AIDS wasting syndrome, organ rejection, autoimmune diseases, allergy, arthritis, Crohn~s disease, malignant gliomas, neurodegenerative diseases, Huntington~s chorea, glaucoma, nausea, anxiety, psychosis, attention deficit hyperactivity disorder, premature ejaculation, and stroke. Another aspect of the present invention relates to combinatorial libraries of amines, and methods for preparing the libraries.

Selon un aspect, l'invention concerne des amines. Selon un autre aspect, l'invention concerne l'utilisation des amines comme inhibiteurs de transporteur d'anandamide de type mammalien. Les composés décrits sont également utiles pour le traitement d'un certain nombre de troubles, d'affections et de maladies dont souffrent les mammifères, y compris mais pas seulement: asthme, douleur neuropathique, douleur persistante, douleur inflammatoire, hyperactivité, hypertension, ischémie cérébrale, maladie de Parkinson, spasticité, syndrome de Gilles de la Tourette, schizophrénie, choc hémorragique, choc septique, choc cardiaque, migraine, céphalée vasculaire de Horton, sclérose en plaques, anorexie, syndrome cachectique, rejet d'organe, maladies auto-immunes, allergie, arthrite, maladie de Crohn, gliomes malins, maladies neurodégénératives, chorée de Huntington, glaucome, nausée, anxiété, psychose, hyperactivité avec déficit de l'attention, éjaculation précoce, et accident vasculaire cérébral. Selon un autre aspect, l'invention concerne des librairies combinatoires d'amines, et des procédés relatifs à leur élaboration.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Amines that inhibit a mammalian anandamide transporter, and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Amines that inhibit a mammalian anandamide transporter, and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amines that inhibit a mammalian anandamide transporter, and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1453642

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.